Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MEDEFIZZ A & MEDEFIZZ B

K-Number: K800843 · 1980-06-17

ApplicantMedefield Pty. , Ltd.
Decision Date1980-06-17
Product CodeKTA
DecisionSubstantially Equivalent

Device Summary

MEDEFIZZ A & MEDEFIZZ B is the device name listed in this FDA 510(k) record. The listed applicant is Medefield Pty. , Ltd.. It received FDA 510(k) clearance on 1980-06-17 under 510(k) number K800843. The device is classified under product code KTA. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MEDEFIZZ A & MEDEFIZZ B?

MEDEFIZZ A & MEDEFIZZ B is a medical device that received FDA 510(k) clearance on 1980-06-17. The listed applicant is Medefield Pty. , Ltd.. The 510(k) number is K800843.

When did MEDEFIZZ A & MEDEFIZZ B receive FDA 510(k) clearance?

MEDEFIZZ A & MEDEFIZZ B received FDA 510(k) clearance on 1980-06-17, under 510(k) number K800843.

Who is the listed applicant for MEDEFIZZ A & MEDEFIZZ B?

The FDA 510(k) record lists Medefield Pty. , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MEDEFIZZ A & MEDEFIZZ B?

The FDA product code for MEDEFIZZ A & MEDEFIZZ B is KTA.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Medefield Pty. , Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K800840MEDEFOAM-2K800839MEDESCANK800841MEDEBAR MK800842MEDEBAR XAC-90K800844MEDEBAR XL

Related Devices (Code: KTA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K800840MEDEFOAM-2Medefield Pty. , Ltd.K800839MEDESCANMedefield Pty. , Ltd.K800841MEDEBAR MMedefield Pty. , Ltd.K800844MEDEBAR XLMedefield Pty. , Ltd.K800842MEDEBAR XAC-90Medefield Pty. , Ltd.K800459BARIUM SULFATE, USP IN SUSPENSIONCentral Pharmaceuticals, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑